ClinicalTrials.gov
ClinicalTrials.gov Menu

Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01452815
Recruitment Status : Completed
First Posted : October 17, 2011
Last Update Posted : April 25, 2013
Sponsor:
Information provided by (Responsible Party):
Tranzyme, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2012
  Actual Study Completion Date : November 2012